JADE:在局部发达未切除的HNSCC患者中对化学放射治疗后顺序提供利利马布的第三阶段研究
Lillian L Siu1, Barbara Burtness2, Kevin Harrington3
1Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada.
这项研究研究了anti-PD-1疗法delarlimab,用于局部发达的头部和部状细胞癌 (HNSCC). 它旨在通过在PD-L1表达患者中化学辐射疗法后顺序施用dtarlimab来改善结果.
科学领域:
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
- 临床试验 临床试验
背景情况:
- 头部和部状细胞癌 (HNSCC) 是一个重大的全球卫生挑战,超过一半的患者被诊断出局部晚期 (LA) 疾病.
- 目前对LA HNSCC的治疗方法,包括化学辐射疗法 (CRT),具有很高的复发率,这凸显了对新型治疗策略的未满足需求.
- 虽然针对编程死亡受体-1 (PD-1) 的免疫检查点抑制剂在复发性/转移性HNSCC中是有效的,但它们在LA HNSCC中与CRT结合时的疗效是可变的.
研究的目的:
- 评估抗PD-1疗法达尔利利马布的疗效和安全性,当在基斯普拉丁基化疗放射治疗 (CRT) 后对局部晚期 (LA) 未切除,PD-L1表达HNSCC的患者进行序列治疗时.
- 解决先前研究的局限性,将PD-L1表达纳入患者选择和dtarlimab后CRT的顺序注射方法.
- 调查delarlimab作为LA HNSCC的新治疗选择的潜力,旨在改善患者的治疗结果.
主要方法:
- 这项JADE研究是一项全球性,多中心,双盲,安慰剂控制,随机的第三期试验.
- 患有LA未切除PD-L1表达的HNSCC的患者将在基于西斯普拉丁的CRT后接受detaerlimab的顺序治疗.
- 该研究将评估无事件生存率作为主要终点,并将整体生存率作为关键的次要终点. 安全性,耐受性和其他结果也将被评估.
主要成果:
- 主要终点是无事件生存率.
- 关键的二次终点是整体存活率.
- 安全性,耐受性,药理动力学,免疫性,生物标志物和患者报告的结果也将被评估.
结论:
- 杜斯塔利马布正在被研究作为化学放射治疗后的顺序治疗,用于局部发达,PD-L1表达的HNSCC.
- 该JADE研究旨在通过优化这种患者群体的免疫疗法治疗来建立新的护理标准.
- 这项试验的结果预计将为PD-1抑制在改善LA HNSCC.结果中的作用提供关键的见解.
更多相关视频
09:38Minimally Invasive Isolated Limb Perfusion (MI-ILP) for Locally Advanced Melanomas and Sarcomas of the Extremity
Published on: January 31, 2025
09:02Percutaneous Hepatic Perfusion PHP with Melphalan as a Treatment for Unresectable Metastases Confined to the Liver
Published on: July 31, 2016
相关概念视频
Phase Diagrams
Phase Transitions
Bioavailability Study Design: Healthy Subjects Versus Patients
Overview of Advanced Functional Groups
Functional groups are groups of atoms with specific chemical properties that occur within organic molecules and are sometimes denoted as “R”. Functional groups can “functionalize” a compound by enabling it to adopt different physical and chemical properties.
Types of Advanced Functional Groups
The table below summarizes some of the major functional groups in organic chemistry.
Extraction: Advanced Methods
Inductance: Single-Phase And Three-Phase Line
Single-Phase Two-Wire Line:
A single-phase line consists of two solid cylindrical conductors, denoted as x and y. Each conductor carries phasor currents ix and iy, respectively. Given that the sum of these currents is...
